Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryoport (CYRX) Capital Expenditures (2016 - 2025)

Cryoport (CYRX) has disclosed Capital Expenditures for 14 consecutive years, with -$10.8 million as the latest value for Q4 2025.

  • On a quarterly basis, Capital Expenditures fell 476.15% to -$10.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $218000.0, a 92.45% decrease, with the full-year FY2025 number at $218000.0, down 92.45% from a year prior.
  • Capital Expenditures was -$10.8 million for Q4 2025 at Cryoport, down from $10.7 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $21.6 million in Q4 2022 to a low of -$14.1 million in Q4 2021.
  • A 5-year average of $1.4 million and a median of $234500.0 in 2021 define the central range for Capital Expenditures.
  • Biggest YoY gain for Capital Expenditures was 4791.61% in 2021; the steepest drop was 8323.26% in 2021.
  • Cryoport's Capital Expenditures stood at -$14.1 million in 2021, then surged by 252.9% to $21.6 million in 2022, then plummeted by 100.6% to -$130000.0 in 2023, then skyrocketed by 2299.23% to $2.9 million in 2024, then plummeted by 476.15% to -$10.8 million in 2025.
  • Per Business Quant, the three most recent readings for CYRX's Capital Expenditures are -$10.8 million (Q4 2025), $10.7 million (Q3 2025), and -$2.9 million (Q2 2025).